FINAL Acne supplement image

Managing acne well—a summary of the 2021 NICE guideline

Commissioned by Galderma UK Ltd

Information intended for UK healthcare professionals only. This promotional supplement has been commissioned and funded by Galderma and developed in partnership with Guidelines.
View Epiduo Gel 0.1% (0.1% adapalene & 2.5% benzoyl peroxide) prescribing information and adverse event reporting information.
View Epiduo Gel 0.3%/2.5 % (0.3% adapalene & 2.5% benzoyl peroxide) prescribing information and adverse event reporting information.
UKI-EDG-2100027
Date of preparation: October 2021

Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.

Advertisement

Macmillan Guidelines 3000x2000 Clinical Native

Cancer can touch every part of your patients’ lives - Macmillan’s Support Line can help them.

This is promotional material from Macmillan Cancer Support.

Our specialist advisers on the Macmillan Support Line will listen, support and help navigate your patients’ needs. From concerns about work, money or side effects to how to discuss their diagnosis with loved ones, we can help. Learn more here.

Webinar icon

The second in a series of half-day virtual events focusing on practical approaches to management of gastrointestinal disorders and iron deficiency

Commissioned by Norgine Pharmaceuticals Limited

Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with GuidelinesPromotional information regarding Norgine Pharmaceutical Limited products will be presented during these webinars.
UK-COR-NP-2100090
Date of preparation: October 2021

Webinar icon

Half-day virtual event focusing on practical approaches to management of gastrointestinal disorders and iron deficiency

Commissioned by Norgine Pharmaceuticals Limited

Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines.
UK-COR-NP-2100043
Date of preparation: July 2021

Su Down video image

Identification of pancreatic exocrine insufficiency (PEI) in patients with diabetes

Commissioned by Viatris

In this video, Su Down looks at the identification of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3287 December 2020

Mike Cummings video 1 image

Assessment of pancreatic exocrine insufficiency (PEI) in primary care

Commissioned by Viatris

In this video, Professor Michael Cummings looks at the assessment of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3288 December 2020

Mike Cummings video 2 image

Management of pancreatic exocrine insufficiency (PEI) in primary care

Commissioned by Viatris

In this video, Professor Michael Cummings looks at the management of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3289 December 2020

index

Management of common eye conditions: blepharitis

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) explains the symptoms and management of blepharitis.

index 2

Management of common eye conditions: conjunctivitis

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) describes the causes, symptoms, and treatment of conjunctivitis.

dry eye index image

Management of common eye conditions: dry eye

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) covers the presentation, causes, and treatment of dry eye.

foreign bodies index image

Management of common eye conditions: corneal and subtarsal foreign bodies

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the symptoms and treatment of foreign bodies in the eye.

chalazion index image 2

Management of common eye conditions: chalazion (meibomian cyst)

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the presentation and management of chalazion (meibomian cyst).

index image

Management of common eye conditions: corneal abrasion

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) discusses the causes, symptoms, and treatment of corneal abrasion.

index image

Management of common eye conditions: subconjunctival haemorrhage

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the appearance and causes of subconjunctival haemorrhage.

episcleritis screenshot 2 (index)

Management of common eye conditions: episcleritis

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the causes, symptoms, and treatment of episcleritis.

Stye index image screenshot

Management of common eye conditions: stye

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the appearance, symptoms, and treatment of stye.

eye drop demo image

Management of common eye conditions: Glaucoma and the #knowyourdrops campaign

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) discusses treatment of glaucoma and techniques for correct eye drop administration.

Introduction 1

Management of common eye conditions: introduction

Funded by Allergan plc

Sarah Thomas and Fiona Chiu introduce a new video series on the management of common eye conditions and the #knowyourdrops eye drops compliance campaign.

Final version - HE algorithm

Management of hepatic encephalopathy in primary care

Commissioned by Norgine Pharmaceuticals Limited

This management algorithm has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
View TARGAXAN® (rifaximin-α) prescribing and adverse event reporting information
UK-HEP-XIF-2100040  October 2021

A nurse consulting with a woman in WPG Yellow

Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes

By Working party–Down Beba Davies Diggle Goel

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd.

doctor & older man 1 260x173

Diabetes and frailty: guidance on the management of older adults with type 2 diabetes

By Strain Down Brown Puttanna and Sinclair

Information intended for UK healthcare professionals only. This summary was developed by Guidelines and Dr Strain, based on the guidance developed by Strain WD et al., with the support of a sponsorship from Novo Nordisk UK.

Stack of fruits, white weight scale and tailor meter on wooden board_AS

Managing obesity in primary care

By Development Group—Tahrani Parretti O’Kane Chowhan Ratcliffe and Le Brocq

This management algorithm was developed by a multidisciplinary expert panel: Tahrani et al with the support of an educational grant from Novo Nordisk Limited. Information intended for UK healthcare professionals.

X-ray (female pelvis) 397x302

Osteoporotic fracture guideline

By Working party—Cooper Javaid Elliott Stephens Tanna

This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.

GSK logo

COPD: LAMA/LABA as initial maintenance therapy for appropriate symptomatic patients

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200014 V3.0 | October 2021

GSK logo

COPD: LAMA/LABA therapy—Real life case studies

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015 V2.0

GSK logo

Why you might want to review patients with COPD receiving a LAMA

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013

GSK logo

COPD: Have you done enough to implement guidelines?

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012

GSK logo

Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011

GSK logo

LAMA/LABAs as initial maintenance therapy in COPD

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200010